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Hepatitis B virus (HBV) variants with impaired expression of e antigen (HBeAg) frequently arise at the chronic stage of infection, as
exemplified by precore and core promoter mutants. Since an intramolecular disulfide bond maintains the secondary structure of HBeAg, we
explored effect of missense mutations of either cysteine codon. Consistent with earlier reports, substitution of each cysteine rendered HBeAg
nearly undetectable. With underlying nucleotide changes at the loop of pregenome encapsidation signal, the C-7 mutants were severely
impaired in pregenomic RNA packaging and hence DNA replication. Although none of the missense mutations at C61 reduced DNA
replication, replacement with arginine, but not alanine, aspartic acid, phenylalanine, or serine, blocked virion secretion. Consistent with the
detection of C61R genome from a patient serum, secretion block of the C61R mutant could be overcome by co-expression of wild-type core
protein. In conclusion, point mutations of the C61 codon may generate viable HBeAg-negative variants.
D 2004 Elsevier Inc. All rights reserved.
Keywords: Disulfide bond; HBV variant; HBeAg; Pregenome encapsidation signal; DNA replication; Virion secretionIntroduction
Hepatitis B e antigen (HBeAg) is an auxiliary protein of
the hepatitis B virus (HBV) that is not essential for viral
replication in vitro yet crucial for establishing persistent
infection in vivo, as experimentally demonstrated for the
related woodchuck hepatitis virus (Chen et al., 1992; Tong
et al., 1991). It has been proposed that HBeAg expression
during neonatal transmission promote immune tolerance
(Milich et al., 1990). Furthermore, it may buffer immune
response against the related core protein (Milich and
Liang, 2003;). Expression of HBeAg requires the coding
capacity of both the precore region and the core gene. Of
the 29 residues specified by the precore region, the first 190042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2004.11.029
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E-mail address: Shuping_Tong_MD@Brown.edu (S. Tong).residues serve as a signal peptide to target the protein to
the endoplasmic reticulum, where the peptide is cleaved
(Bruss and Gerlich, 1988; Ou et al., 1986). Subsequently,
the arginine-rich carboxyl terminus of the protein is
clipped away by a furin-like endopeptidase in the secretory
pathway before the mature protein of 17 kDa is released
into the blood stream (Messageot et al., 2003). Therefore,
HBeAg contains 10 extra amino acids at its N-terminus
than the core protein but lacks about 30 residues at the C-
terminus. Consistent with the nonessential nature of
HBeAg for HBV life cycle, the development of anti-HBe
antibodies in the late stage of HBV infection often
correlates with emergence of viral variants with impaired
expression of HBeAg. The replacement of the wild-type
virus by the HBeAg variants is possibly associated with
the ability of the variants to avoid clearance mediated by
anti-HBe immunity (Zhang and Summers, 1999). Among
the known HBeAg variants, the core promoter mutants05) 216–224
Fig. 1. Schematic view of the HBeAg biosynthesis pathway and its
modulation by naturally occurring mutations. Although a G1862T mutation
was suspected to reduce HBeAg expression at the step of signal peptide
removal, our recent work failed to support this hypothesis (Guarnieri et al.,
in preparation). On the other hand, naturally occurring mutations in the
RRDRGR motif, the furin cleavage site, have been found to reduce HBeAg
secretion (Kim et al., in preparation).
Table 1
Constructs used in this study
Name Nucleotide Amino acid DNA
replication
Virion
secretion
N4 WT WT +++++ OK
G5 G1881T C-7F + OK
G33 T1880G C-7G  NA
G34 T1880A C-7S + OK
G35 T1880C C-7R ++ OK
G6 T2081C C61R +++++ defective
G7 G2082C C61S +++++ OK
G17 T2081G/G2082C C61A +++++ OK
G18 T2081G/G2082A C61D +++++ OK
G19 G2082T C61F +++++ OK
NA: not applicable.
G. Bang et al. / Virology 332 (2005) 216–224 217express less HBeAg owing to transcriptional down
regulation of its mRNA (Buckwold et al., 1996; Li et
al., 1999; Okamoto et al., 1994; Parekh et al., 2003;
Scaglioni et al., 1997; Tang et al., 2001; Yu and Mertz,
2003; Zheng et al., 2004), whereas precore mutants fail to
express HBeAg because of a nonsense or frameshift
mutation that terminates translation prematurely (Carman
et al., 1989; Li et al., 1990; Tong et al., 1990). In addition,
HBeAg translation can be prevented by a point mutation of
the precore ATG codon, or mitigated by mutations of its
Kozak sequence (Ahn et al., 2003; Raimondo et al., 1990).
Considering the many steps involved in the biosynthetic
pathway for HBeAg, it is worthwhile to explore whether
there are additional avenues whereby the virus can evade
the anti-HBe immunity of its host (Fig. 1). This is
especially relevant for genotype A and certain strains of
genotypes C and F, which rarely develop the HBeAg-
minus G1896A mutation due to base-pairing requirement
between nucleotides 1896 and 1858 in the pregenome
encapsidation signal (e signal) (Alestig et al., 2001; Arauz-
Ruiz et al., 1997; Li et al., 1993; Lok et al., 1994;
Rodriguez-Frias et al., 1995).
Despite their extensive overlap of the primary sequen-
ces, HBeAg and core protein adopt very different higher
structures. For example, HBeAg does not oligomerize to
form particles. The unique secondary structure of secreted
HBeAg has been attributed to its N-terminal 10 residues,
which are derived from the precore region and hence
absent in core protein. Indeed, C23 of the precore
peptide (4th residue of mature HBeAg, -7 position
relative to residue 1 specified by the core gene) forms
an intramolecular disulfide bond with C61 specified by
the core gene (Nassal and Rieger, 1993; Wasenauer et
al., 1993). Because of this intra-molecular S–S bond
between C-7 and C61, molecular dimerization via C61–C61 disulfide bridge, as occurs in the core protein, is
prevented. Mutation of either cysteine residue is known
to greatly reduce HBe antigenicity (Nassal and Rieger,
1993; Wasenauer et al., 1993). In addition, mutating C61
impairs secretion of the variant HBeAg molecule (Nassal
and Rieger, 1993). Mutants of C-7 have been found
during chronic HBV infection (Erhardt et al., 2000).
However, a comparative study of HBV DNA between
the tumorous vs. nontumorous parts of the liver revealed
exclusive distribution of the missense mutations of the C-7
codon in the tumor tissue, where viral replication has
ceased (Manzin et al., 1992). To determine whether the C-7
and C61 mutants are viable, we generated site-directed
mutants and tested their biological properties by trans-
fection experiments in the Huh7 human hepatoma cells.Results and discussion
Missense mutations of the C-7 codon markedly impair
genome replication
Based on the previous reports of naturally occurring
mutations at the C-7 codon (Erhardt et al., 2000; Manzin et
al., 1992), four site-directed mutants were generated: C-7F,
C-7G, C-7S, and C-7R (Table 1). The parental construct for
this study, N4, is characterized by high replication capacity
as well as efficient expression of both hepatitis B surface
antigen (HBsAg) and HBeAg (Khan et al., 2004). Tandem
dimers of the constructs were generated for transfection into
Huh7 hepatoma cells using the lipofectamine method,
together with a plasmid encoding secreted alkaline phos-
phatase (SEAP). Cells and culture supernatants were
harvested at day 5 post-transfection. The transfection
efficiencies were comparable among various constructs, as
indicated by similar levels of SEAP and HBsAg in culture
supernatant (Fig. 2A). According to assays performed with a
commercial radioimmunoassay, all the four mutants pro-
duced negligible HBeAg in culture supernatant (Fig. 2A).
The lack of detectable HBeAg is most likely caused by
conformational change of the protein, rather than due to a
Fig. 2. Protein expression and genome replication of site-directed mutants in transfected Huh7 cells. Cells were co-transfected with HBV dimer and a plasmid-
encoding SEAP, and were harvested at day 5 post-transfection. Small aliquots of the harvested culture supernatant were used for the measurement of SEAP,
HBsAg, and HBeAg, while the bulk was used for pelleting secreted viral particles by ultracentrifugation. Core particles were isolated from the cell lysate. HBV
DNA associated with intracellular core particles and pelleted extracellular viral particles were detected by Southern blot analysis. (A) Quantification of SEAP,
HBsAg, HBeAg from culture supernatant and HBV DNA from intracellular core particles (the corresponding autoradiography is shown in top panel B). Lack
of detectable HBeAg in the culture supernatant is most likely caused by the conformational change of the protein, which prevents recognition by the
monoclonal antibodies used in the assay (Nassal and Rieger, 1993; Wasenauer et al., 1993). (B) Southern blot analysis of intracellular and extracellular viral
DNA. PDS: partially double-stranded DNA; RC: relaxed circular DNA; SS: single-stranded DNA. NG: negative control (cells transfected with HBV 5.4, which
is deficient in viral replication and HBeAg expression owing to a frameshift mutation in the core gene; Parekh et al., 2003). Although both virions and naked
core particles were pelleted down by ultracentrifugation of culture supernatant, our previous study has established association of SS DNA with naked core
particles, and PDS/RC DNA with virions (Parekh et al., 2003).
G. Bang et al. / Virology 332 (2005) 216–224218true loss of protein expression (Nassal and Rieger, 1993;
Wasenauer et al., 1993).
Southern blot analysis of intracellular core particles
revealed greatly reduced viral DNA replication of the C-7
mutants, although there is no difference in the pattern of
HBV DNA bands (Fig. 2B). Reflecting the sequential steps
involved in HBV replication, the major bands in the
Southern blot correspond to single-stranded (SS), partiallydouble stranded (PDS), and the mature relaxed circular
(RC) DNA forms. Based on phosphoimage analysis,
replication capacity of the mutants ranged from 20% of
the wild-type level (C-7R) to a complete loss of replication
(C-7G) (Fig. 2A). The C-7F and C-7S constructs displayed
intermediate replication capacity, at about 10% of the wild-
type level. The mutations did not affect virion secretion, as
evidenced by similar degree of reduction in DNA signals
G. Bang et al. / Virology 332 (2005) 216–224 219in culture supernatant as inside core particles (Fig. 2B,
compare bMediumQ with bCellQ). The transfection experi-
ments were repeated at least two more times and very
similar results were obtained (data not shown). The
reduced viral replication may well be caused by the
underlying nucleotide changes, rather than by amino acid
substitutions in HBeAg protein, which is dispensable for
viral replication in vitro (Tong et al., 1991). Although the
precore region specifies the signal peptide of HBeAg
protein when present at the 5V end of HBeAg mRNA, it
has no coding function for pregenomic RNA due to the
lack of precore AUG codon. Instead, it forms a stem-loop
structure that directs the packaging of pregenomic RNA
into core protein particles, a step preceding viral DNA
replication (Fig. 3, left panel) (Junker-Niepmann et al.,
1990). As shown in Table 1, the C-7G, C-7S, C-7R, and
C-7F substitutions are achieved by single point mutations
at nucleotide 1880 or 1881 of the loop of the q signal,
which is crucial for RNA packaging and extremely
sensitive to perturbation. Single nucleotide substitutions
in the loop have been found to abolish packaging of
pregenomic RNA and hence viral replication (Knaus and
Nassal, 1993; Pollack and Ganem, 1993; Tong et al.,
1992).Fig. 3. The replication defect of the C-7 mutants lies at the step of pregenome enca
signal. Mutations of the C-7 studied here cover nucleotides 1880 and 1881, which
point mutations involving nucleotide 1880, the nucleotide transition (T1880C) in
encapsidation of pregenomic RNA from the C-7 mutants. Total RNAwas isolated
RNA, intracellular core particles were concentrated from cell lysate by ultracentrif
were detected by primer extension analysis. Positions of the two RNA species a
markers.The replication defect of the C-7 mutants lies at the step of
pregenome packaging
Consistent with the cis effect of the C-7 mutations,
nucleotide transition at position 1880 (T188 8C/C-7R)
impaired viral genome replication less dramatically than
nucleotide transversions (T1880G/8C-7G and T1880A/8C-
7S) (Fig. 2A and Table 1). Primer extension assay of total
cellular RNA revealed similar levels of precore and pre-
genomic RNAs produced from cells transfected with the
wild-type genome, T188 8C, T1880A, and T1880G mutants
(Fig. 3, right panel). However, pregenomic RNA associated
with core particles was reduced in the three mutants
progressively, with virtually no such RNA in cells trans-
fected with the T1880G and T1880A mutants. Thus,
nucleotide changes at 1880 indeed impair viral replication
at the step of pregenomic RNA encapsidation.
Mutations of the C61 codon do not compromise viral
replication
We have recently characterized dozens of naturally
occurring genotype A isolates of HBV (Parekh et al.,
2003). While analyzing full-length clones derived frompsidation. (Left panel) The secondary structure of pregenome encapsidation
are located in the loop of the pregenome encapsidation signal. Of the three
curred least reduction in viral replication. (Right panel) Transcription and
from transfected cells by Trizol reagent. To extract encapsidated pregenomic
ugation through sucrose cushion. The precore and pregenomic RNA species
re indicated. End-labeled HaeIII fragments of fx174 DNA served as size
Fig. 4. Defective virion secretion of the C61R mutant. Culture supernatants
of cells transfected with the C61R and C61S mutants were centrifuged over
sucrose cushion to pellet down virions and naked core particles. Next, the
pellets were dissolved in TEN buffer containing CsCl and centrifuged for
48 h. Gradient fractions of 400 Al were collected from the top, weighed to
obtain density values, and used for DNA extraction and Southern blot
analysis. Fractions F6–F8 have densities typical of virions, while fractions
F10 and F11 have densities of naked core particles. PDS: partially double
stranded DNA; RC: relaxed circular DNA; SS: single-stranded DNA. It is
evident that virions harbor double-stranded viral genome, whereas core
particles contain single-stranded genome. The C61R mutant did not secrete
virions.
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HBeAg expression despite the lack of core promoter or
precore mutation. Sequence analysis revealed a single
T2081C nucleotide change that converted codon 61 of the
core gene from cysteine (TGC) into arginine (CGC). This
C61R mutation and an artificial C61S mutation were
separately introduced into clone N4 (Table 1). Transfection
experiments revealed greatly reduced HBeAg levels of both
mutants consistent with the loss of HBe antigenicity (Fig.
2A). In contrast to the C-7 mutants, neither mutant of C61
was compromised in DNA replication (Fig. 2B). In this
regard, Nassal (1992) observed sustained viral replication
when C61 and three additional cysteines (C48, C107, C183)
were mutated to serines. Thus, although C61 is thought to
mediate core protein dimerization, its substitution by serine
does not affect core protein functions such as particle
formation, pregenome packaging, and DNA replication.
However, results presented below revealed impairment of
virion secretion by the C61R mutation.
The C61R mutant is defective in virion secretion
In Huh-7 cells transfected with HBV DNA, both virions
and naked core particles can be detected in culture super-
natant. However, secreted virions contain the more mature
forms of viral genome (RC and PDS), while viral DNA
inside naked core particles remain in the immature single-
stranded state (Parekh et al., 2003). Pattern of HBV DNA
present in the culture supernatant of the C61S mutant is
similar to the N4 parental clone (Fig. 2B, lower panel). This
finding is in agreement with the previous report that the
C48S/C61S/C107S/C183S quadruple mutant is secretion
competent (Nassal, 1992). In contrast, the extracellular
particles of the C61R mutant were devoid of the PDS and
RC DNA forms. Further separation of extracellular particles
by ultracentrifugation in cesium chloride gradient confirmed
such single stranded genome as part of naked core particles,
which have higher densities than virions (Fig. 4). Particles
with density of virions and PDS/RC DNA forms were
observed for the C61S but not C61R variant.
The ability of a single C61R missense mutation in the
core gene to abolish virion secretion is striking. Never-
theless, the neighboring L60V mutation has been found to
reduce virion secretion while the L60A mutation totally
blocked virion secretion (Le Pogam et al., 2000; Ponsel and
Bruss, 2003). To determine the specificity of the arginine
mutation on virion secretion, we generated three additional
mutants of this residue: C61A, C61D, and C61F. Trans-
fection experiments revealed normal DNA replication and
virion secretion capacities of all the three new constructs
(Fig. 2), suggesting that a positive (but not negative) charge
at residue 61 is incompatible with virion secretion. In this
regard, a short linear sequence in the preS1/Pre-S2 region of
the L protein is essential for virion formation and possibly
involved in physical contact with core particles (Bruss,
1997). This sequence contains several conserved arginineresidues. We speculate that C61 of core protein is positioned
close to an arginine residue of the L protein, and the C61R
mutation repels core particle contact with L protein, thus
impeding virion formation. If this hypothesis is correct, then
a compensatory mutation in the pre-S domain of L protein
may restore virion formation in the C61R mutant.
Secretion of viral particles containing the C61R mutant
genome through co-expression of wild-type core protein
From the patient serum where the C61R mutant was
derived, other clones contained wild-type sequence at the
C61 codon (data not shown). To determine how the C61R
genome could be released into patient serum, we performed
co-transfection experiment of the C61R mutant with two
expression constructs of wild-type core protein (in terms of
residue 61). Artificial constructs 2A p/q and 4B p/q
are incapable of replication due to a null polymerase gene
and nonfunctional q signal, although they continue to
express bwild-typeQ core protein. Such replication deficient
constructs could each rescue the virion secretion defect of
the C61R mutant, as suggested by the appearance of PDS
and RC DNA forms in association with particles concen-
trated from culture supernatant (Fig. 5A). Furthermore,
CsCl2 gradient centrifugation of extracellular particles
derived from C61R/4Bp/q co-transfected cells followed
by Southern blot analysis of gradient fractions confirmed
virion secretion (Fig. 5B). The more potent effect of the 4B
p/q construct in rescuing virion secretion may be related
to its higher level of core protein. Clone 4B is a core
Fig. 5. Rescue of the secretion defect of the C61R mutant by co-expression
of wild-type core protein. (A) The C61R construct (1 Ag) was co-
transfected with 1 Ag of either pcDNAvector, or the core protein expression
constructs: 2A p/q, 4B p/q (simplified as 2A and 4B in the figure).
Intracellular HBV DNA replication and extracellular HBV DNA were
determined by Southern blot. Values of HBsAg in culture supernatant were
determined. The 2A p/q and 4B p/q constructs are replication deficient
due to mutated q signal and a nonsense mutation in the polymerase gene.
(B) Culture supernatant was pooled from 6 wells of 6-well plates of Huh7
cells co-transfected with C61R and 4B p/q mutants. Virions and naked
core particles were concentrated by ultracentrifugation through 20%
sucrose cushion, and further separated in CsCl2 gradient. Fractions were
taken from top and analyzed for HBV DNA (see legend to Fig. 4 for
details). The results confirm the restoration of virion secretion by the co-
expression of wild-type core protein.
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levels of core protein (unpublished observation). Our
findings indicate that the mutant core protein, albeit unable
to support virion secretion, does not block virion formation
mediated by the wild-type core protein. Certainly, we do
not know whether mosaic core particles with both wild-
type core protein and C61R mutant were formed and
enveloped.In conclusion, single missense mutations of the C61
codon may effectively destroy HBe antigenicity without
compromising viral genome replication or virion secretion,
as exemplified by the C61S (G2082C) and C61F (G2082T)
mutants. Single point mutations of the C-7 codon will
greatly impair packaging of pregenomic RNA, an essential
step in viral replication cycle. Such a defect may explain
why C-7 mutations were found in liver cancer tissues
lacking active viral replication but not in adjacent non-
tumorous tissues, where viral replication persisted (Manzin
et al., 1992). Since genotype A of HBV is compromised in
conversion into HBeAg-minus mutants through the
G1896A nonsense mutation in the precore region (Li et
al., 1993), missense mutations of C61 may represent an
alternative avenue of escaping the anti-HBe immunity.
Further studies are needed to evaluate the prevalence of
the C61 mutation in genotype A strains at the anti-HBe
stage of infection.Materials and methods
Site-directed mutants
Clone N4 is based on the naturally occurring core
promoter mutant called 3.4 (Parekh et al., 2003), with the
AvrII–EcoRV fragment replaced by sequence from clone 4B
(Khan et al., 2004). This replacement restored efficient
HBsAg detection. The site-directed mutants generated for
this study are listed in Table 1. Each mutation was
introduced by overlap extension polymerase chain reaction
(PCR), using High Fidelity PCR system (Roche). First, two
separate PCR reactions of 50 Al were performed: the 1501
sense primer (5V-GTCTGCCGTTCCAGCCGA-3V) together
with the mutagenic antisense primer, and in another tube,
mutagenic sense primer in conjunction with 2664 antisense
primer (5V-GGATAGAATCTAGCAGGCA-3V). Each PCR
reaction employed 100 AM of dNTP, 1 AM of primers, 100
ng of template DNA, and 1 u of polymerase. Samples were
denatured at 95 8C for 5 min, followed by 23 cycles of
amplification (95 8C for 1 min, 50 8C for 1 min, and 72 8C
for 2.5 min). The two PCR products were gel purified, and a
1/25th were combined as templates for the second round of
PCR (25 cycles), which employed 1501 and 2664 primers.
The PCR products were double digested with either RsrII–
BspE1 or RsrII–ApaI, and cloned into the same sites of
clone N4. The PCR-derived region of each mutant was
verified by customer sequence analysis at the Keck
Laboratory of Yale University. Each mutant construct was
converted into tandem dimer version in the EcoRI site of
pUC18 vector (Parekh et al., 2003). The plasmid DNA was
purified by a commercial kit (Marligen), further extracted
with phenol and chlorofom/isoamyl alcohol, and dissolved
in TE buffer.
Two replication-deficient dimers capable of core protein
expression were used for the rescue of virion secretion defect
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were derived from 2A and 4B genomes, respectively (Parekh
et al., 2003), by introduction of G1879T/T1880A double
mutation into the loop of the q signal, as well as a C2589T
nonsense mutation into the polymerase gene. The mutants
were converted into tandem dimer in the EcoRI site of
pUC18 vector. Due to the defective q signal, these two
genomes cannot be packaged into core particles.
Transfection
The HBV dimers were transfected into Huh7 hepatoma
cells via TransIT Transfection system (Mirus), together with
SEAP cDNA to control for variation in transfection
efficiency. Serum-free MEM medium (150 Al) was mixed
with 4 Al of trans-LT1 reagent by vortex, and incubated at
room temperature for 15 min with additional vortex.
Following addition of 1.5 Ag of HBV dimer DNA and 0.1
Ag of pSEAP2 DNA (Clontech), samples were further
incubated for 15 min, and added dropwise to Huh7 cells
grown in 6-well plates (9.4 cm2/well). Cells had been
seeded the day before transfection at around 4  105/well
using complete MEM medium (containing 10% fetal bovine
serum), and were 50–80% confluent at the time of
transfection. Following overnight incubation, cells were
washed once, and cultured in complete MEM medium at
37 8C for 4 additional days before harvesting. No medium
change was performed during this period. As a negative
control for replication, HBV clone 5.4, which is defective
in genome replication and HBeAg expression due to a
single nucleotide deletion in the core gene (Parekh et al.,
2003), was transfected in parallel. For the trans-comple-
mentation assays shown in Fig. 5, a total of 2 Ag of DNA
(for example, 1 Ag of C61R DNA plus 1Ag of 2A p/q
DNA) was transfected to each well of the 6-well plates.
Analysis of HBV DNA replication and virion secretion
The details of these assays have been described else-
where (Parekh et al., 2003). Briefly, HBV genome
replication was measured by Southern blot analysis of
DNA associated with intracellular core particles. Extrac-
ellular viral particles (both naked core particles and
enveloped Dane particles) were concentrated by ultracen-
trifugation through 10–20% sucrose cushion, and DNAwas
extracted for Southern blot analysis. In experiments where
further separation of Dane particles from core particles was
necessary, concentrated particles were resuspended in 4.5 ml
of TEN buffer. CsCl (1.5 g) was added and dissolved, and
samples were spun in a Sorvall SW65 rotor at 46,000 rpm,
12 8C for 48 h. Aliquots of 400 Al were taken from the top,
weighed, and dialyzed against TEN buffer to remove CsCl.
CaCl2 and MgCl2 were added to final concentrations of 8
and 6 mM, respectively, and samples were treated with 1 U
of DNaseI and 1.5 U of mung bean nuclease at 37 8C for 15
min. Next, samples were treated with 0.5 mg/ml ofproteinase K in the presence of 25 mM Tris (pH 7.5), 10
mM EDTA, and 0.5% SDS. DNA was extracted by phenol,
precipitated with ethanol using glycogen as a carrier. HBV
DNAwas detected by Southern blot analysis. Quantification
of viral DNA in the Southern blots was achieved by
phosphoimage analysis, using model STORM820 (Molec-
ular Dynamics) and ImageQuant software.
Primer extension analysis of total and encapsidated
pregenomic RNA
Huh7 cells from one well of 6-well plates were trans-
fected with 2 Ag of HBV dimer DNA. RNA was harvested
at day 3 post-transfection with 1 ml of Trizol (Invitrogen),
extracted with chloroform, and precipitated with isopropa-
nol. The RNA pellet was dissolved in nuclease-free water,
and 10 Ag was incubated at 58 8C for 30 min with the anti-
sense primer 5V-GACTCTAAGGCTTCTCGATACAGAG-
3Vin the AMV reverse transcriptase buffer (the AMV reverse
transcription kit from Promega). The oligonucleotide had
been labeled with g-32P ATP using polynucleotide kinase.
Following cooling down for 10 min at room temperature,
the annealed oligonucleotide was extended by AMV reverse
transcriptase at 42 8C for 30 min. The product was heated at
90 8C for 10 min before separation in a 4% acrylamide gel
containing 7M urea. As a molecular size marker, HaeIII-
digested fx-174 DNA was end labeled with g-32P ATP and
run in parallel. The gel was dried and DNA signals were
revealed by autoradiography.
For analysis of encapsidated pregenomic RNA, cells
derived from two wells of 6-well plates of Huh7 cells were
harvested at day 3 post-transfection, and lysed with 400 Al
of a buffer containing 10 mM HEPES, 100 mM NaCl, 1 mM
EDTA, and 1% NP40. The lysate was layered on top of 20%
sucrose solution prepared in TEN buffer, and centrifuged
overnight at 46,000 rpm in the Sorvall SW65 rotor to pellet
core particles. The solution was removed except for the
bottom 100 Al, and the pellet was resuspended by vortex.
The volume was brought up to 150 Al with TEN buffer, and
non-encapsidated RNA was degraded by Staphylococcus
aureus nuclease (2 Ag/ml) at 37 8C for 40 min, in the
presence of 2.5 mM CaCl2. Next, 240 Al of proteinase K
buffer (25 mM Tris, pH 7.5, 100 mM NaCl, 10 mM EDTA,
0.5% SDS) was added, and core particles were digested at
37 8C for 1 h with proteinase K (50 Ag/ml). Nucleic acids
were extracted with phenol, and precipitated with isopropa-
nol in the presence of glycogen. Following resuspension in
water, primer extension assay was performed in the same
manner as described for total RNA.
Measurement of HBsAg, HBeAg, and SEAP
HBeAg present in culture supernatant was detected by
the EBK 125I Radioimmunoassay Kit (DiaSorin) using 5 Al
of samples. The values shown in Fig. 2A are enzymatic
activities 10-7. The HBsAg was measured from 5 Al of
G. Bang et al. / Virology 332 (2005) 216–224 223culture supernatant by the Auszyme Monoclonal HBsAg Kit
(Abbot Laboratories). Secreted alkaline phosphatase was
measured from 12 Al of culture supernatant, using the Great
EscAPe SEAP reporter system (BD Biosciences). The
values shown in Fig. 2A are enzymatic activities 10-7.Acknowledgments
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